0001127602-22-003279.txt : 20220204 0001127602-22-003279.hdr.sgml : 20220204 20220204094442 ACCESSION NUMBER: 0001127602-22-003279 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirchgraber Paul R CENTRAL INDEX KEY: 0001791393 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 22591606 MAIL ADDRESS: STREET 1: 531 SOUTH SPRING STREET CITY: BURLINGTON STATE: NC ZIP: 27215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-02 0000920148 LABORATORY CORP OF AMERICA HOLDINGS LH 0001791393 Kirchgraber Paul R 531 SOUTH SPRING STREET BURLINGTON NC 27215 1 CEO, Covance Drug Development Common Stock 2022-02-02 4 M 0 443 A 9396 D Common Stock 2022-02-02 4 F 0 144 273.18 D 9252 D Restricted Stock Unit 2022-02-02 4 M 0 443 0 D Common Stock 443 4331 D Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Stock withholding to satisfy tax withholding obligations. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022. This number reflects the aggregate number of Restricted Stock Units held by the reporting person. /s/ Sandra van der Vaart, Attorney-in-Fact for Paul R. Kirchgraber 2022-02-04